221 related articles for article (PubMed ID: 24726362)
1. ARF and p53 coordinate tumor suppression of an oncogenic IFN-β-STAT1-ISG15 signaling axis.
Forys JT; Kuzmicki CE; Saporita AJ; Winkeler CL; Maggi LB; Weber JD
Cell Rep; 2014 Apr; 7(2):514-526. PubMed ID: 24726362
[TBL] [Abstract][Full Text] [Related]
2. Cooperation between Rb and Arf in suppressing mouse retinoblastoma.
Conkrite K; Sundby M; Mu D; Mukai S; MacPherson D
J Clin Invest; 2012 May; 122(5):1726-33. PubMed ID: 22484813
[TBL] [Abstract][Full Text] [Related]
3. ISG15 Deficiency Enhances HIV-1 Infection by Accumulating Misfolded p53.
Osei Kuffour E; König R; Häussinger D; Schulz WA; Münk C
mBio; 2019 Aug; 10(4):. PubMed ID: 31455647
[TBL] [Abstract][Full Text] [Related]
4. The TRIP from ULF to ARF.
Collado M; Serrano M
Cancer Cell; 2010 Apr; 17(4):317-8. PubMed ID: 20385357
[TBL] [Abstract][Full Text] [Related]
5. Deregulated beta-catenin induces a p53- and ARF-dependent growth arrest and cooperates with Ras in transformation.
Damalas A; Kahan S; Shtutman M; Ben-Ze'ev A; Oren M
EMBO J; 2001 Sep; 20(17):4912-22. PubMed ID: 11532955
[TBL] [Abstract][Full Text] [Related]
6. Targeting of C-terminal binding protein (CtBP) by ARF results in p53-independent apoptosis.
Paliwal S; Pande S; Kovi RC; Sharpless NE; Bardeesy N; Grossman SR
Mol Cell Biol; 2006 Mar; 26(6):2360-72. PubMed ID: 16508011
[TBL] [Abstract][Full Text] [Related]
7. Transcription-independent ARF regulation in oncogenic stress-mediated p53 responses.
Chen D; Shan J; Zhu WG; Qin J; Gu W
Nature; 2010 Mar; 464(7288):624-7. PubMed ID: 20208519
[TBL] [Abstract][Full Text] [Related]
8. Novel ARF/p53-independent senescence pathways in cancer repression.
Chan CH; Gao Y; Moten A; Lin HK
J Mol Med (Berl); 2011 Sep; 89(9):857-67. PubMed ID: 21594579
[TBL] [Abstract][Full Text] [Related]
9. BAL1/ARTD9 represses the anti-proliferative and pro-apoptotic IFNγ-STAT1-IRF1-p53 axis in diffuse large B-cell lymphoma.
Camicia R; Bachmann SB; Winkler HC; Beer M; Tinguely M; Haralambieva E; Hassa PO
J Cell Sci; 2013 May; 126(Pt 9):1969-80. PubMed ID: 23487038
[TBL] [Abstract][Full Text] [Related]
10. Deleting key autophagy elongation proteins induces acquirement of tumor-associated phenotypes via ISG15.
Kong E; Kim HD; Kim J
Cell Death Differ; 2020 Aug; 27(8):2517-2530. PubMed ID: 32127658
[TBL] [Abstract][Full Text] [Related]
11. Isg15 controls p53 stability and functions.
Huang YF; Wee S; Gunaratne J; Lane DP; Bulavin DV
Cell Cycle; 2014; 13(14):2200-10. PubMed ID: 24844324
[TBL] [Abstract][Full Text] [Related]
12. Activation of IFN/STAT1 signalling predicts response to chemotherapy in oestrogen receptor-negative breast cancer.
Legrier ME; Bièche I; Gaston J; Beurdeley A; Yvonnet V; Déas O; Thuleau A; Château-Joubert S; Servely JL; Vacher S; Lassalle M; Depil S; Tucker GC; Fontaine JJ; Poupon MF; Roman-Roman S; Judde JG; Decaudin D; Cairo S; Marangoni E
Br J Cancer; 2016 Jan; 114(2):177-87. PubMed ID: 26695443
[TBL] [Abstract][Full Text] [Related]
13. Different requirements for the cytostatic and apoptotic effects of type I interferons. Induction of apoptosis requires ARF but not p53 in osteosarcoma cell lines.
Sandoval R; Xue J; Pilkinton M; Salvi D; Kiyokawa H; Colamonici OR
J Biol Chem; 2004 Jul; 279(31):32275-80. PubMed ID: 15169789
[TBL] [Abstract][Full Text] [Related]
14. Egr1 mediates p53-independent c-Myc-induced apoptosis via a noncanonical ARF-dependent transcriptional mechanism.
Boone DN; Qi Y; Li Z; Hann SR
Proc Natl Acad Sci U S A; 2011 Jan; 108(2):632-7. PubMed ID: 21187408
[TBL] [Abstract][Full Text] [Related]
15. Adipose Tissue-Derived Mesenchymal Stem Cells Suppress Growth of Huh7 Hepatocellular Carcinoma Cells via Interferon (IFN)-β-Mediated JAK/STAT1 Pathway
Byun CS; Hwang S; Woo SH; Kim MY; Lee JS; Lee JI; Kong JH; Bae KS; Park IH; Kim SH; Eom YW
Int J Med Sci; 2020; 17(5):609-619. PubMed ID: 32210710
[TBL] [Abstract][Full Text] [Related]
16. p19Arf represses platelet-derived growth factor receptor β by transcriptional and posttranscriptional mechanisms.
Widau RC; Zheng Y; Sung CY; Zelivianskaia A; Roach LE; Bachmeyer KM; Abramova T; Desgardin A; Rosner A; Cunningham JM; Skapek SX
Mol Cell Biol; 2012 Nov; 32(21):4270-82. PubMed ID: 22907756
[TBL] [Abstract][Full Text] [Related]
17. MDM2-ARF complex regulates p53 sumoylation.
Chen L; Chen J
Oncogene; 2003 Aug; 22(34):5348-57. PubMed ID: 12917636
[TBL] [Abstract][Full Text] [Related]
18. Oncogene-mediated regulation of p53 ISGylation and functions.
Huang YF; Bulavin DV
Oncotarget; 2014 Jul; 5(14):5808-18. PubMed ID: 25071020
[TBL] [Abstract][Full Text] [Related]
19. ISG15 inhibits IFN-α-resistant liver cancer cell growth.
Wan XX; Chen HC; Khan MA; Xu AH; Yang FL; Zhang YY; Zhang DZ
Biomed Res Int; 2013; 2013():570909. PubMed ID: 24024201
[TBL] [Abstract][Full Text] [Related]
20. ISGylation governs the oncogenic function of Ki-Ras in breast cancer.
Burks J; Reed RE; Desai SD
Oncogene; 2014 Feb; 33(6):794-803. PubMed ID: 23318454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
